Nustendi

bempedoic acid; ezetimibe · Daiichi Sankyo Europe GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nustendi, covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: EMA Authorised: Nustendi (bempedoic acid;ezetimibe) — Daiichi Sankyo Europe GmbH